Neonatal 5-hydroxytryptamine depletion induces depressive-like behavior in adult rats

Polish Journal of Pharmacology

Volumn 55, Issue 6, 2003, Pages 957-963

  Kostowski, Wojciech ^a,b   Krzqścik, Paweł ^b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

5,7 dihydroxytryptamine; 5 hydroxytryptamine; Depression; Neonatal lesion

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5,7 DIHYDROXYTRYPTAMINE; CATECHOLAMINE; DESIPRAMINE; DOPAMINE; FLUOXETINE; HOMOVANILLIC ACID; SEROTONIN; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DEVELOPMENTAL STAGE; DISEASE MODEL; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; NEUROCHEMISTRY; NEWBORN; NONHUMAN; OPEN FIELD TEST; PHYSICAL ACTIVITY; RAT; SEROTONIN RELEASE;

5,7-DIHYDROXYTRYPTAMINE; AGING; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN; DEPRESSION; FEMALE; MALE; PREGNANCY; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGENTS; SWIMMING;

EID: 1642543985     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ashby C.J. Jr., Zhang J.Y., Edwards E., Wang R.Y.: The induction of serotonin 3-like receptor supersensitivity and dopamine receptor subsensitivity in the rat medial prefrontal cortex after the intraventricular administration of neurotoxin 5,7-dihydroxytryptamine: a microiontophoretic study. Neuroscience, 1994, 60, 453-462.
2. Bieńkowski P., Koroś E., Kostowski W.: Novelty-seeking behavior and operant oral ethanol self-administration in Wistar rats. Alcohol Alcoholism, 2001, 36, 525-528.
3. Borsini F.: Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev., 1995, 19, 377-395.
4. Bresse G.R., Cooper B.R.: Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats. Brain Res., 1975, 98, 517-527.
5. Brus R., Kostrzewa R.M., Perry K.W., Fuller R.W.: Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. J. Pharmacol. Exp. Ther., 1994, 268, 231-237.
6. Bunney W.E. Jr., Davis J.M.: Norepinephrine in depressive reactions. A review. Arch. Gen. Psychiat., 1965, 13, 483-494.
7. Carpenter L.L., Andersen G.M., Pelton G., Gudin J.A., Kirwin P.D., Price L.H.: Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology, 1998, 19, 26-35.
8. Cervo L., Grignashi G., Rossi C., Samanin R.: Role of central serotonergic neurons in the effect of sertraline in rats in the forced swim test. Eur. J. Pharmacol., 1991, 196, 217-222.
9. Cervo L., Grignaschi G., Samanin R.: Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: involvement of metabolite. Life Sci., 1988, 43, 2095-2102.
10. Cervo L., Rossi C., Samanin R.: The role of serotonin and dopamine in brain in the antidepressant-like effect of clonidine in the forced swimming test. Neuropharmacology, 1992, 31, 331-335.
11. 1A receptor agonist. Eur. J. Pharmacol., 1987, 144, 223-229.
12. Cesana R., Ceci A., Cipriandi C., Borsini F.: Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced-swim test in mice. J. Pharm. Pharmacol., 1993, 45, 473-475.
13. Conreras C.M., Rodriguez-Landa J., Gutierrez-Garcia A., Bernal-Molralos B.: The lowest effective dose of fluoxetine in the forced swim test significantly affects the firing rate of lateral septal nucleus neurons in the rat. J. Psychopharmacol., 2001, 15, 231-236.
14. Delgado P.L., Price L.H., Miller H.L., Salomon R., Licinio J., Krystal J.H.: Rapid serotonin depletion as a provocative test for patients with major depression. Psychopharmacol. Bull., 1991, 27, 321-330.
15. Jessa M., Krzaścik P., Kostowski W.: Neonatal treatment with 5,7-dihydroxytryptamine induces decrease in alcohol drinking in adult animals. Pol. J. Pharmacol., 2001, 53, 109-116.
16. 1A receptor agonists in animal models of depression and anxiety. Pharmacol. Toxicol., 1992, 71, 24-30.
17. Lytle L. D., Jacoby J. H., Nelson M. E., Baumgarten H. G.: Long-term effects of 5,7-dihydroxytryptamine administered at birth on development of brain mono-amines. Life Sci., 1974, 15, 1203-1217.
18. Olausson P., Akesson P., Petersson A., Engel J.E., Soderpalm B.: Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat. Psychopharmacology, 2001, 155, 348-361.
19. Parsons L.H., Justice J.B.: Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res., 1993, 606, 195-199.
20. Porsolt R.D.: Behavioral despair test. In: Antidepressants: Neurochemical, Behavioural and Clinical Perspectives. Eds. Enna S.J., Malick J.B., Richelson E., Raven Press, New York, 1981, 129-139.
21. Porsolt R.D., Anton G., Blavet N., Jalfre M.: Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol., 1978, 47, 379-391.
22. Sachs C., Jonsson G.: 5,7-Dihydroxytryptamine-induced changes in the postnatal development of central 5-hydroxytryptamine neurons. Med. Biol., 1975, 53, 156-164.
23. Schildkraut J.J.: The catecholamine hypothesis of affective disorder: a review of supporting evidence. Amer. J. Psychiat., 1965, 122, 1032-1039.
24. Schreiber R., Brocco M., Gobert A., Veiga S., Milan M.J.: The potential activity of the 5-HT-1A receptor agonists S 14506 and S 14671 in the rat forced swim test is blocked by novel 5-HT-1A receptor antagonists. Eur. J. Pharmacol., 1994, 271, 537-541.
25. 1A receptor agonists 8-OHDPAT and ipsapirone in the rat forced swimming test. Behav. Pharmacol., 1993, 6, 625-636.
26. Shopsin B., Friedman E., Gershon S.: Parachlorophenylalanine reversal of tranylcypromine effects in depressed patient. Arch. Gen. Psychiat., 1976, 33, 811-819.
27. Smith K.A., Fairburn C.G., Cowen P.I.: Relapse of depression after rapid depletion of tryptophan. Lancet, 1997, 349, 915-919.
28. Spillmann M., Van der Does A.J., Rankin M., Vuolo R., Alpert J., Nierenberg A., Rosenbaum J., Hayden D., Schoenfeld D., Fava M.: Tryptophan depletion in SSRI-recovered depressed outpatients. Psychopharmacology, 2001, 155, 123-127.
29. 1A receptor agonists. Neuropsychopharmacology, 1995, 32, 977-985.
30. Van Praag H.M.: Studies on the mechanism of action of serotonin precursors in depression. Psychopharmacol. Bull., 1984, 20, 599-602.
31. Yan Q.S.: Activation of 5-HT 2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission. Brain Res. Bull., 2000, 51, 75-81.